Multimodal NDGA Drug Delivery System for Metabolic Regulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current oral delivery methods for nordihydroguaiaretic acid (NDGA) face challenges in achieving optimal absorption kinetics and physiological delivery profiles, leading to inadequate regulation of glucose and triglyceride levels in patients with diabetes and metabolic disorders, with immediate release formulations resulting in rapid elimination and frequent dosing requirements.
Innovation Solution
A multimodal drug delivery system for NDGA, featuring a bimodal release profile with a first portion released in the stomach and a second portion released in the small intestines, allowing for pH-dependent release and absorption, ensuring at least 90% of NDGA is absorbed before reaching the large intestines, thereby optimizing absorption kinetics and reducing the total dose and dosing frequency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Speed
If immediate release formulation of NDGA is used, then absorption speed is improved, but duration of action deteriorates due to rapid elimination requiring frequent dosing
Solution Approach 1:
The NDGA formulation is segmented into multiple release components: an immediate release portion for rapid absorption and a sustained release portion for prolonged action. This segmentation allows the formulation to simultaneously achieve fast onset and extended duration of therapeutic effect, resolving the contradiction between absorption speed and duration of action.
2Ease of operation
If water solubility of NDGA is enhanced through derivatization, then absorption is improved, but manufacturing complexity increases due to additional chemical modification steps
Solution Approach 1:
A solubilizing agent or excipient is introduced as an intermediary substance to enhance the water solubility of NDGA without requiring chemical derivatization. This approach improves absorption while avoiding the manufacturing complexity associated with chemical modification steps, as the solubilizing agent can be incorporated through simple mixing or formulation processes.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The multimodal delivery system effectively regulates glucose and triglyceride levels, providing a synergistic effect on metabolic disorders and diabetes by immediately lowering triglycerides and subsequently glucose levels, offering a more convenient dosing regimen and improved patient compliance with reduced toxicity risks.
Implementation Method 1
a first portion of NDGA that is released in the stomach (i.e. its peak release occurs at stomach pH); and a second portion of NDGA that is released in the small intestines
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present invention relates generally to compositions and methods for oral delivery of nordihydroguaiaretic acid (NDGA). More particularly, the present invention relates to pharmacologically optimized multimodal drug delivery systems for orally administered NDGA and methods for preparation and use thereof.